» Articles » PMID: 30886959

Interpretation of DAS28 and Its Components in the Assessment of Inflammatory and Non-inflammatory Aspects of Rheumatoid Arthritis

Overview
Journal BMC Rheumatol
Specialty Rheumatology
Date 2019 Mar 20
PMID 30886959
Citations 24
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Erythrocyte Sedimentation Rate (ESR) in Veterinary Medicine: A Focused Review in Dogs and Cats.

Diamanti D, Pieroni C, Pennisi M, Marchetti V, Gori E, Paltrinieri S Animals (Basel). 2025; 15(2).

PMID: 39858246 PMC: 11758338. DOI: 10.3390/ani15020246.


Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development.

Bedathuru D, Rengaswamy M, Channavazzala M, Ray T, Packrisamy P, Kumar R NPJ Syst Biol Appl. 2024; 10(1):126.

PMID: 39496637 PMC: 11535547. DOI: 10.1038/s41540-024-00454-1.


Exploration of Risk Factors for Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Retrospective Study.

Feng M, Meng F, Jia Y, Wang Y, Ji G, Gao C Inflammation. 2024; .

PMID: 39414673 DOI: 10.1007/s10753-024-02157-5.


Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain.

Georgopoulos V, Smith S, McWilliams D, Ferguson E, Wakefield R, Platts D Arthritis Res Ther. 2024; 26(1):175.

PMID: 39380043 PMC: 11460083. DOI: 10.1186/s13075-024-03407-5.


Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis.

Ke L, He Q, Qu J, Wang X, Li K, Gong X Mol Ther. 2024; 32(12):4497-4513.

PMID: 39367607 PMC: 11638830. DOI: 10.1016/j.ymthe.2024.09.031.


References
1.
Wolfe F . Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol. 2003; 30(2):369-78. View

2.
Smolen J, Breedveld F, Schiff M, Kalden J, Emery P, Eberl G . A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003; 42(2):244-57. DOI: 10.1093/rheumatology/keg072. View

3.
Aletaha D, Ward M, Machold K, Nell V, Stamm T, Smolen J . Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum. 2005; 52(9):2625-36. DOI: 10.1002/art.21235. View

4.
Fransen J, Van Riel P . The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S93-9. View

5.
Hyrich K, Watson K, Silman A, Symmons D . Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2006; 45(12):1558-65. DOI: 10.1093/rheumatology/kel149. View